Bradesco stock price hovers near a 52-week high as Brazil rate decision nears, earnings next week

Bradesco stock price hovers near a 52-week high as Brazil rate decision nears, earnings next week

New York, Jan 28, 2026, 11:23 (ET) — Regular session

  • Banco Bradesco’s shares on the U.S. market nudged up 0.1% in early trading, hovering close to their recent peaks
  • Brazil’s central bank is set to announce its policy decision Wednesday, following inflation figures that reached the upper limit of the target range
  • Bradesco will release its fourth-quarter results on Feb. 5, followed by a call scheduled for Feb. 6

Shares of Banco Bradesco S.A. listed in the U.S. edged up Wednesday, staying near a 52-week high. Investors held back ahead of Brazil’s interest-rate announcement scheduled for later and digested a flurry of company updates ahead of next week’s earnings. (Investing)

This matters now because of rates. Brazilian banks often react to the Selic, the country’s key benchmark rate, since it influences loan demand, funding costs, and credit stress on household balance sheets.

This week’s focus centers on inflation figures and the central bank’s Copom policy committee kicking off its 2026 decisions. Traders are betting on a pause now, with rate cuts on the horizon. That uncertainty has left bank stocks jittery, despite a slow corporate news flow.

Bradesco’s ADRs changed hands at $4.145, edging up roughly 0.1%, following an earlier range between $4.135 and $4.20.

Shares of Brazil-linked financial rivals saw gains: Itaú Unibanco’s U.S.-listed stock climbed roughly 1.5%, Santander Brasil’s ADRs gained about 0.4%, and Nubank’s Nu Holdings moved slightly higher.

Brazil’s IPCA-15 inflation index, a key early gauge of official inflation, ticked up 0.20% in January. That lifted the annual rate to 4.50%, right at the top end of the central bank’s target band. The Copom meeting on Wednesday is widely expected to hold rates steady. Still, investors are eager for hints on whether rate cuts might begin as soon as March. (CNN Brasil)

William Jackson, chief emerging markets economist at Capital Economics, said the 4.5% figure will probably “remove any lingering expectations” of a rate cut at this meeting, though he still anticipates easing to begin in March. (Capital Economics)

This week on Latibex in Madrid, Bradesco revised its tax rate and per-share net values for the monthly “interest on shareholders’ equity” — a Brazilian cash distribution akin to dividends — but left its payment timetable intact. (Latibex)

The lender also announced its next annual general meeting is set for March 10.

Bradesco announced it has renewed its agreement with payments company Cielo. The deal, labeled a related-party transaction, involves services aimed at attracting and retaining merchants for possible accreditation within the Cielo system.

Bradesco bulls face a clear risk: should Copom take a hawkish turn beyond what investors anticipate—or if inflation picks up again—expect rate-cut bets to unravel quickly, dragging bank shares lower. Signs of rising provisions or deteriorating credit quality in Bradesco’s upcoming results would only intensify this pressure.

Attention is now on Wednesday’s central bank decision and Bradesco’s Q4 report, set for Feb. 5 after markets close in Brazil and New York. The bank will hold a management videoconference the next morning, Feb. 6, at 8:30 a.m. ET. (Bradesco RI)

Stock Market Today

  • NorthWest Healthcare Properties REIT (TSX:NWH.UN) Shows Mixed Valuation Signals Amid Recent Gains
    January 28, 2026, 11:38 AM EST. NorthWest Healthcare Properties REIT (TSX:NWH.UN) has recorded a 1.6% gain in a day and about 11% over the past month, with a 1-year total return near 32%. Despite this momentum, longer-term returns over 3 and 5 years remain weak. The unit's current trading price of CA$5.67 equates to a price-to-earnings (P/E) ratio of 28.5, higher than its peer average of 7.4 and fair benchmark of 25, indicating a potentially overvalued status. The REIT's recent profitability and low Return on Equity (1.9%) contrast with its high P/E, reflecting investor optimism amid modest earnings. A discounted cash flow (DCF) model suggests a fair value of CA$7.85, about 27.8% above the current price, pointing to possible undervaluation. Revenue decline of 3.4% and weak longer-term returns pose risks to the optimistic outlook.
UnitedHealth (UNH) stock rebounds after rout — what investors watch next on Medicare Advantage rates
Previous Story

UnitedHealth (UNH) stock rebounds after rout — what investors watch next on Medicare Advantage rates

AT&T stock price jumps on 2026 outlook as fiber, spectrum deals come into focus
Next Story

AT&T stock price jumps on 2026 outlook as fiber, spectrum deals come into focus

Go toTop